There is hope out there, there is help out there, just be willing to ask for it.” That’s the message Sharon Reed wants to ...

Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal ... that ensure rapid opioid reversal.

About Polyrizon Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form ... that ensure rapid opioid reversal.

RAANANA, Israel - Polyrizon Ltd. (NASDAQ:PLRZ), a micro-cap biotech firm with a market capitalization of $3.46 million focused on developing nasal hydrogels, has launched preclinical studies for an ...

About Polyrizon Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form ... that ensure rapid opioid reversal.

and we believe it holds the potential to enhance intranasal Naloxone by offering higher bioavailability for increased drug effectiveness and optimized drug release profiles that ensure rapid opioid ...

platform holds the potential to enhance intranasal Naloxone by offering higher bioavailability for increased drug effectiveness and optimized drug release profiles that ensure rapid opioid reversal.

These preclinical studies mark a step forward in evaluating Polyrizon’s Trap and Target™ (T&T) platform for the intranasal administration of Naloxone, an opioid antagonist designed to rapidly ...

[13] The potential medical and social costs of opiate dependence during pregnancy are great. Pregnant opiate-dependent women experience a 6-fold increase in obstetric complications and significant ...